Transport across the blood-brain barrier: Stereoselectivity and PET-tracers

Molecular Imaging and Biology

Volumn 6, Issue 5, 2004, Pages 306-318

  Luurtsema, Gert ^a   de Lange, Elizabeth C M ^b   Lammertsma, Adriaan A ^a   Franssen, Eric J F ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

BBB; Blood brain barrier; PET; Positron emission tomography; Stereoselectivity; Tracers

Indexed keywords

5 (7 BENZOFURANYL) 8 CHLORO 2,3,4,5 TETRAHYDRO 7 HYDROXY 3 METHYL 1H 3 BENZAZEPINE; AMINE OXIDASE (FLAVIN CONTAINING); AMINO ACID TRANSPORTER; BENZODIAZEPINE RECEPTOR; BETA FLUOROMETHYLENE META TYROSINE; CARBON 11; CARRIER PROTEIN; CHOLINERGIC RECEPTOR; COCAINE; CYCLOFOXY; DEXMETHYLPHENIDATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; EPIBATIDINE; FLUORINE 18; GLYCOPROTEIN P; KETAMINE; METHIONINE C 11; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NICOTINE; NICOTINIC RECEPTOR; OPIATE RECEPTOR; RACLOPRIDE; SELEGILINE; SEROTONIN TRANSPORTER; TRACER; UNINDEXED DRUG; VERAPAMIL;

BLOOD BRAIN BARRIER; COMPARATIVE STUDY; DRUG BIOAVAILABILITY; DRUG DIFFUSION; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG TRANSPORT; ENANTIOMER; HUMAN; ISOTOPE LABELING; NONHUMAN; PERMEABILITY BARRIER; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RECEPTOR BINDING; REVIEW; STEREOCHEMISTRY;

EID: 4544315183     PISSN: 15361632     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mibio.2004.06.008     Document Type: Article

References (63)

1. T.N. Calvey Isomerism and anaesthetic drugs Acta Anaesthesiol. Scand. Suppl. 106 1995 83-90
2. I.W. Wainer C.P. Granvil Stereoselective separations of chiral anticancer drugs and their application to pharmacodynamic and pharmacokinetic studies Ther. Drug Monit. 15 1993 570-575
3. B. Vogelgesang H. Echizen E. Schmidt et al. Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique Br. J. Clin. Pharmacol. 18 1984 733-740
4. H. Echizen T. Brecht S. Niedergesass et al. The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans Am. Heart J. 109 1985 210-217
5. M. Nishimura K. Sato Ketamine stereoselectively inhibits rat dopamine transporter Neurosci. Lett. 274 1999 131-134
6. W.M. Meylan P.H. Howard Atom/fragment contribution method for estimating octanol-water partition coefficients J. Pharm. Sci. 84 1995 83-92
7. E.C. de Lange M. Danhof Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain Clin. Pharmacokinet. 41 2002 691-703
8. T. Terasaki K. Hosoya The blood-brain barrier efflux transporters as a detoxifying system for the brain Adv. Drug Deliv. Rev. 36 1999 195-209
9. S.M. Gloor M. Wachtel M.F. Bolliger et al. Molecular and cellular permeability control at the blood-brain barrier Brain Res. Brain Res. Rev. 36 2001 258-264
10. E.M. Taylor The impact of efflux transporters in the brain on the development of drugs for CNS disorders Clin. Pharmacokinet. 41 2002 81-92
11. V.A. Levin Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability J. Med. Chem. 23 1980 682-684
12. A. Tsuji I.I. Tamai Carrier-mediated or specialized transport of drugs across the blood-brain barrier Adv. Drug Deliv. Rev. 36 1999 277-290
13. R. Bendayan G. Lee M. Bendayan Functional expression and localization of P-glycoprotein at the blood brain barrier Microsc. Res. Tech. 57 2002 365-380
14. W.H. Oldendorf Brain uptake of radiolabeled aminoacids, amines and hexoses after arterial injection Am. J. Physiol. 221 1974 1629-1639
15. W.M. Pardridge M.B. Davidson D. Casanello-Ertl Glucose and amino acid metabolism in an established line of skeletal muscle cells J. Cell. Physiol. 96 1978 309-318
16. R. Polt F. Porreca L.Z. Szabo et al. Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier Proc. Natl. Acad. Sci. USA 91 1994 7114-7118
17. P.L. Jager W. Vaalburg J. Pruim et al. Radiolabeled amino acids: basic aspects and clinical applications in oncology J. Nucl. Med. 42 2001 432-445
18. K.L. Leenders W.H. Poewe A.J. Palmer et al. Inhibition of L-[18F]Fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography Ann. Neurol. 20 1986 258-262
19. Y. Wang D.F. Welty The simultaneous estimation of the influx and efflux blood-brain barrier permeabilities of gabapentin using a microdialysis-pharmacokinetic approach Pharm. Res. 13 1996 398-403
20. C. Halldin K.O. Schoeps S. Stone-Elander et al. The Bucherer-Strecker synthesis of D- and L-(1-11C)tyrosine and the in vivo study of L-(1-11C)tyrosine in human brain using positron emission tomography Eur. J. Nucl. Med. 13 1987 288-291
21. I. Tamai A. Tsuji Drug delivery through the blood-brain barrier Adv. Drug Deliv. Rev. 19 1996 401-424
22. D.D. Allen P.R. Lockman The blood-brain barrier choline transporter as a brain drug delivery vector Life. Sci. 73 2003 1609-1615
23. M. Marchi F. Bergaglia A. Pedrini et al. Study of the bidirectional transport of choline by blocking choline carriers from outside or inside brain nerve terminals J. Neurosci. Res. 61 2000 533-540
24. S.S. Ferguson M. Diksic B. Collier Stereospecificity of high- and low-affinity transport of choline analogues into rat cortical synaptosomes J. Neurochem. 57 1991 915-921
25. G. Lee S. Dallas M. Hong et al. Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations Pharmacol. Rev. 53 2001 569-596
26. T.R. Stouch O. Gudmundsson Progress in understanding the structure-activity relationships of P-glycoprotein Adv. Drug Deliv. Rev. 54 2002 315-328
27. G. Toffoli F. Simone G. Corona et al. Structure-activity relationship of verapamil analogs and reversal of multidrug resistance Biochem. Pharmacol. 50 1995 1245-1255
28. S. Vogelgesang I. Cascorbi E. Schroeder et al. Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans Pharmacogenetics. 12 2002 535-541
29. A. Siddiqui R. Kerb M.E. Weale et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1 N. Engl. J. Med. 348 2003 1442-1448
30. W.E. Evans H.L. Mcleod Pharmacogenetics-drug disposition, drug targets, and side effects N. Engl. J. Med. 348 2003 538-549
31. J. Bart H.J. Groen W.T. van der Graaf et al. An oncological view on the blood-testis barrier Lancet Oncol. 3 2002 357-363
32. J. Wijnholds Drug resistance caused by multidrug resistance-associated proteins Novartis Found. Symp. 243 2002 69-79
33. M. Bergstrom H. Lundqvist K. Ericson et al. Comparison of the accumulation kinetics of L-(methyl-11C)-methionine and D-(methyl-11C)-methionine in brain tumors studied with positron emission tomography Acta Radiol. 28 1987 225-229
34. O.T. DeJesus J.E. Holden C. Endres et al. Visualization of dopamine nerve terminals by positron tomography using [18F]fluoro-beta-fluoromethylene-m-tyrosine Brain Res. 597 1992 151-154
35. S.C. Huang J. Quintana N. Satyamurthy et al. [18F] fluoro-beta-fluoromethylene-m-tyrosine derivatives show stereo, geometrical, and regio specificities as in vivo central dopaminergic probes in monkeys Nucl. Med. Biol. 26 1999 365-370
36. G. Lacan N. Satyamurthy J.R. Barrio Synthesis of stereo (R and S) and geometric (E and Z) isomers of [18F]fluoro-beta-fluoromethylene-m-tyrosine derivatives: in vivo probes of central dopaminergic function Nucl. Med. Biol. 26 1999 359-363
37. J.T. Patt J.E. Spang G. Westera et al. Synthesis and in vivo studies of [C-11]N-methylepibatidine: comparison of the stereoisomers Nucl. Med. Biol. 26 1999 165-173
38. C. Halldin K. Nagren C.G. Swahn et al. (S)- and (R)-[11C]nicotine and the metabolite (R/S)-[11C]cotinine. Preparation, metabolite studies and in vivo distribution in the human brain using PET Int. J. Rad. Appl. Instrum. B 19 1992 871-880
39. A. Nordberg A. Lilja H. Lundqvist et al. Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography Neurobiol. Aging. 13 1992 747-758
40. J.T. Patt J.E. Spang A. Buck et al. Synthesis and in vivo studies of the stereoisomers of N-[11C]methyl-homoepibatidine Nucl. Med. Biol. 28 2001 645-655
41. J.S. Fowler N.D. Volkow G.J. Wang et al. [(11)]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy Nucl. Med. Biol. 28 2001 561-572
42. D. Xing P. Chen R. Keil et al. Synthesis, biodistribution, and primate imaging of fluorine-18 labeled 2betacarbo-1′-fluoro-2-propoxy-3beta-(4-chlorophenyl)Tr opanes. Ligands for the imaging of dopamine transporters by positron emission tomography J. Med. Chem. 43 2000 639-648
43. Y.S. Ding J.S. Fowler N.D. Volkow et al. Chiral drugs: comparison of the pharmacokinetics of [11C]d-threo and L-threo-methylphenidate in the human and baboon brain Psychopharmacology (Berl.) 131 1997 71-78
44. L. Farde S. Pauli H. Hall et al. Stereoselective binding of 11C-raclopride in living human brain - a search for extrastriatal central D2-dopamine receptors by PET Psychopharmacology (Berl.) 94 1988 471-478
45. C. Halldin C. Foged Y.H. Chou et al. Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors J. Nucl. Med. 39 1998 2061-2068
46. Z. Szabo P.F. Kao U. Scheffel et al. Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652 Synapse 20 1995 37-43
47. T. Kakiuchi H. Tsukada D. Fukumoto et al. Effects of aging on serotonin transporter availability and its response to fluvoxamine in the living brain Synapse 40 2001 170-179
48. D.F. Smith A.D. Gee S.B. Hansen et al. Uptake and distribution of a new SSRI, NS2381, studied by PET in living porcine brain Eur. Neuropsychopharmacol. 9 1999 351-359
49. P. Hartvig J. Valtysson G. Antoni et al. Brain kinetics of (R)- and (S)-[N-methyl-11C]ketamine in the rhesus monkey studied by positron emission tomography (PET) Nucl. Med. Biol. 21 1994 927-934
50. R.A. Koeppe K.A. Frey D.E. Kuhl et al. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine J. Cereb. Blood Flow Metab. 19 1999 1376-1384
51. J.S. Fowler R.R. MacGregor A.P. Wolf et al. Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET Science 235 1987 481-485
52. A. Plenevaux S.L. Dewey J.S. Fowler et al. Synthesis of (R)-(-)- and (S)-(+)-4-fluorodeprenyl and (R)-(-)- and (S)-(+)-[N-11C-methyl]-4-fluorodeprenyl and positron emission tomography studies in baboon brain J. Med. Chem. 33 1990 2015-2019
53. F. Shah S.P. Hume V.W. Pike et al. Synthesis of the enantiomers of [N-Methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats Nucl. Med. Biol. 21 1994 573-581
54. Y. Kwon A.V. Kamath M.E. Morris Inhibitors of P-glycoprotein-mediated daunomycin transport in rat liver canalicular membrane vesicles J. Pharm. Sci. 85 1996 935-939
55. P.W. Wigler F.K. Patterson Reversal agent inhibition of the multidrug resistance pump in human leukemic lymphoblasts Biochim. Biophys. Acta 1189 1994 1-6
56. G. Luurtsema olthoff A.D. Windhorst et al. (R)- and (S)-[ 11 C]verapamil as PET-tracers for measuring P-glycoprotein function: in vitro and in vivo evaluation Nucl. Med. Biol. 30 2003 747-751
57. S.P. Hume R. Myers P.M. Bloomfield et al. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography Synapse 12 1992 47-54
58. A.A. Lammertsma C.J. Bench S.P. Hume et al. Comparison of methods for analysis of clinical [11C]raclopride studies J. Cereb. Blood Flow Metab. 16 1996 42-52
59. A.A. Lammertsma S.P. Hume Simplified reference tissue model for PET receptor studies Neuroimage 4 1996 153-158
60. N.A. Lassen P.A. Bartenstein A.A. Lammertsma et al. Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle J. Cereb. Blood Flow Metab. 15 1995 152-155
61. L. Farde L. Eriksson G. Blomquist et al. Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET - a comparison to the equilibrium analysis J. Cereb. Blood Flow Metab. 9 1989 696-708
62. R. Kawai Y. Sawada M. Channing et al. BBB transport and rapid tissue binding of cyclofoxy: comparison of active and inactive Eenantiomers Am. J. Physiol. 259 1990 1278-1287
63. R. Kawai R.E. Carson B. Dunn et al. Regional brain measurement of Bmax and KD with the opiate antagonist cyclofoxy: equilibrium studies in the conscious rat J. Cereb. Blood Flow Metab. 11 1991 529-544